Literature DB >> 2539332

Androgen receptors, androgen-dependent proliferation, and 5 alpha-reductase activity of small-cell lung cancer cell lines.

M Maasberg1, M Rotsch, G Jaques, U Enderle-Schmidt, R Weehle, K Havemann.   

Abstract

We investigated the influence of testosterone on binding to established small-cell lung cancer (SCLC) cell lines and were able to show specific high-affinity and low-capacity binding sites in some cell lines with a typical receptor size, using sucrose density gradient centrifugation. In addition, we demonstrated marked growth stimulation with testosterone and dehydrotestosterone using different androgen-receptor-positive small-cell lung cancer cell lines. This growth stimulation could be counteracted by the addition of anti-androgens like cyproterone acetate or flutamide. The presence of 5 alpha-reductase activity, 17 beta-hydroxysteroid-dehydrogenase and 3 alpha-hydroxysteroid-dehydrogenase activities could be demonstrated, suggesting testosterone metabolism of small-cell lung cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539332     DOI: 10.1002/ijc.2910430424

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  The future of antihormone therapy: innovations based on an established principle.

Authors:  K Parczyk; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  New perspectives in lung cancer. 2. Growth factors and lung cancer.

Authors:  P J Woll
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

3.  Plasma testosterone in the general population, cancer prognosis and cancer risk: a prospective cohort study.

Authors:  D D Ørsted; B G Nordestgaard; S E Bojesen
Journal:  Ann Oncol       Date:  2014-03       Impact factor: 32.976

Review 4.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

5.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Androgen pathway manipulation and survival in patients with lung cancer.

Authors:  Craig Harlos; Grace Musto; Pascal Lambert; Rashid Ahmed; Marshall W Pitz
Journal:  Horm Cancer       Date:  2015-03-20       Impact factor: 3.869

7.  Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations.

Authors:  Siddhartha Devarakonda; Sumithra Sankararaman; Brett H Herzog; Kathryn A Gold; Saiama N Waqar; Jeffrey P Ward; Victoria M Raymond; Richard B Lanman; Aadel A Chaudhuri; Taofeek K Owonikoko; Bob T Li; John T Poirier; Charles M Rudin; Ramaswamy Govindan; Daniel Morgensztern
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

8.  Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.

Authors:  Yi X Chan; Helman Alfonso; S A Paul Chubb; David J Handelsman; P Gerry Fegan; Graeme J Hankey; Jonathan Golledge; Leon Flicker; Bu B Yeap
Journal:  Horm Cancer       Date:  2017-02-23       Impact factor: 3.869

9.  Expression of vitamin D receptor in lung cancer.

Authors:  U Kaiser; M Schilli; B Wegmann; P Barth; S Wedel; J Hofmann; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

10.  Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.

Authors:  Úna C Mc Menamin; Andrew T Kunzmann; Michael B Cook; Brian T Johnston; Liam J Murray; Andrew D Spence; Marie M Cantwell; Chris R Cardwell
Journal:  Int J Cancer       Date:  2018-03-30       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.